Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

Gaballa MR, Julian K, Afrough A, Hansen DK, Goel U, De Menezes Silva Corraes A, Dima D, Rana M, Hosoya H, Mikkilineni L, Fogel L, Raza S, Banerjee R, Zanwar SS, Pasvolsky O, Sannareddy A, Borogovac A, Davis J, Green K, Biran N, Zolotov E, Herr M, Shune L, Ouchveridze E, DeJarnette S, Atrash S, Ferreri C, Richards T, Abid MB, Bal S, Ali HM, Ye JC, Richard S, Kaur G, Shain K, Castaneda-Puglianini O, Harada K, De Avila G, Rossi A, Hassan H, Anderson LD, Voorhees PM, Khouri J, Sidana S, Portuguese AJ, Janakiram M, Lee HC, Lin Y, Grajales-Cruz A, Patel KK, Sborov DW

Open source

DOI
10.1182/bloodadvances.2026020826
Published
2026 Sep 8
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026020826,
  title = {Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.},
  author = {Gaballa MR and Julian K and Afrough A and Hansen DK and Goel U and De Menezes Silva Corraes A and Dima D and Rana M and Hosoya H and Mikkilineni L and Fogel L and Raza S and Banerjee R and Zanwar SS and Pasvolsky O and Sannareddy A and Borogovac A and Davis J and Green K and Biran N and Zolotov E and Herr M and Shune L and Ouchveridze E and DeJarnette S and Atrash S and Ferreri C and Richards T and Abid MB and Bal S and Ali HM and Ye JC and Richard S and Kaur G and Shain K and Castaneda-Puglianini O and Harada K and De Avila G and Rossi A and Hassan H and Anderson LD and Voorhees PM and Khouri J and Sidana S and Portuguese AJ and Janakiram M and Lee HC and Lin Y and Grajales-Cruz A and Patel KK and Sborov DW},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026020826},
  url = {https://doi.org/10.1182/bloodadvances.2026020826}
}

RIS

TY  - JOUR
TI  - Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.
AU  - Gaballa MR
AU  - Julian K
AU  - Afrough A
AU  - Hansen DK
AU  - Goel U
AU  - De Menezes Silva Corraes A
AU  - Dima D
AU  - Rana M
AU  - Hosoya H
AU  - Mikkilineni L
AU  - Fogel L
AU  - Raza S
AU  - Banerjee R
AU  - Zanwar SS
AU  - Pasvolsky O
AU  - Sannareddy A
AU  - Borogovac A
AU  - Davis J
AU  - Green K
AU  - Biran N
AU  - Zolotov E
AU  - Herr M
AU  - Shune L
AU  - Ouchveridze E
AU  - DeJarnette S
AU  - Atrash S
AU  - Ferreri C
AU  - Richards T
AU  - Abid MB
AU  - Bal S
AU  - Ali HM
AU  - Ye JC
AU  - Richard S
AU  - Kaur G
AU  - Shain K
AU  - Castaneda-Puglianini O
AU  - Harada K
AU  - De Avila G
AU  - Rossi A
AU  - Hassan H
AU  - Anderson LD
AU  - Voorhees PM
AU  - Khouri J
AU  - Sidana S
AU  - Portuguese AJ
AU  - Janakiram M
AU  - Lee HC
AU  - Lin Y
AU  - Grajales-Cruz A
AU  - Patel KK
AU  - Sborov DW
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026020826
UR  - https://doi.org/10.1182/bloodadvances.2026020826
ER  -

APA

MR, G., K, J., A, A., DK, H., U, G., A, D. M. S. C., D, D., M, R., H, H., L, M., L, F., S, R., R, B., SS, Z., O, P., A, S., A, B., J, D., K, G., N, B., E, Z., M, H., L, S., E, O., S, D., S, A., C, F., T, R., MB, A., S, B., HM, A., JC, Y., S, R., G, K., K, S., O, C., K, H., G, D. A., A, R., H, H., LD, A., PM, V., J, K., S, S., AJ, P., M, J., HC, L., Y, L., A, G., KK, P., & DW, S. (2026). Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020826

Source records